The FDAs announcement on tirzepatide for chronic weight management explains the approved weight-management use
Benefits of Semaglutide For Patients With Obesity And Alcohol Use Disorder Patients with both obesity and alcohol use disorder face unique challenges that require comprehensive care
So that, so that's really stood out to me and it's not surprising at all based on what you shared that they quit because who, who, I would want to do that
After this period, bacterial contamination risk increases and drug stability decreases
Additional symptoms include foot pain, an increased risk for corns and calluses, and a higher risk for foot ulcers, especially for individuals with diabetes
Conversely, cytotoxic effects were observed with a DHA dose greater than 5 mM